OXAZEPAM
Active substance: oxazepam
CAPSULE · OXAZEPAM 15 mg/1
United StatesActive
Marketing holder: Leading Pharma, LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- OXAZEPAM · 15 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
Import and control
Control by country
- RussiacontrolledSchedule: ПIII
Source: GRLS (Russian state register) · record 01a120c3-b0b5-7c61-a1ef-f6b5a8631b45,01a120c4-2e13-7939-9d1b-6b301e2eab94,01a120c4-3bb6-709b-a193-ce1711098b6c,01a120c6-a1eb-77c9-bbea-b4a74d18f736;count=4 · valid from 2026-10-09 · verified 2026-10-09
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208c-72ab-74ba-a133-bdfab0e3a9ce,01a1208c-83ef-741d-9c51-1bcc6b7597b6,01a1208c-8a9e-7f11-ab22-f62a39b40c2b,01a1208e-9d6b-766e-a77d-71334d631532,01a1208e-9d70-79d8-b76a-c1cfb39ba395;count=16 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69315-912
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 69315-912 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69315-912 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69315-912 · Verified 2026-10-09 · open in source